Search by Drug Name or NDC
NDC 23155-0524-41 Tranexamic Acid 1 g/10mL Details
Tranexamic Acid 1 g/10mL
Tranexamic Acid is a INTRAVENOUS INJECTION, SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Heritage Pharmaceuticals Labs Inc. d/b/a Avet Pharmaceuticals Labs Inc.. The primary component is TRANEXAMIC ACID.
Product Information
| NDC | 23155-0524 |
|---|---|
| Product ID | 23155-524_d209501e-305d-4d22-9673-e8bdd54728dc |
| Associated GPIs | 84100040002025 |
| GCN Sequence Number | 068183 |
| GCN Sequence Number Description | tranexamic acid VIAL 1000 MG/10 INTRAVEN |
| HIC3 | M9D |
| HIC3 Description | ANTIFIBRINOLYTIC AGENTS |
| GCN | 30912 |
| HICL Sequence Number | 002802 |
| HICL Sequence Number Description | TRANEXAMIC ACID |
| Brand/Generic | Generic |
| Proprietary Name | Tranexamic Acid |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Tranexamic Acid |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | INJECTION, SOLUTION |
| Route | INTRAVENOUS |
| Active Ingredient Strength | 1 |
| Active Ingredient Units | g/10mL |
| Substance Name | TRANEXAMIC ACID |
| Labeler Name | Heritage Pharmaceuticals Labs Inc. d/b/a Avet Pharmaceuticals Labs Inc. |
| Pharmaceutical Class | Antifibrinolytic Agent [EPC], Decreased Fibrinolysis [PE] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA203521 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 23155-0524-41 (23155052441)
| NDC Package Code | 23155-524-41 |
|---|---|
| Billing NDC | 23155052441 |
| Package | 10 VIAL, GLASS in 1 CARTON (23155-524-41) / 10 mL in 1 VIAL, GLASS (23155-524-31) |
| Marketing Start Date | 2014-08-13 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |